Discredited Stem Cell Researcher Fired

The researcher who falsely claimed to treat human patients with their own stem cells is dismissed, but insists that he did perform the procedure on one patient.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Tokyo Medical and Dental University. Wikimedia Commons, Rs1421The University of Tokyo last week (October 19) dismissed Hisashi Moriguchi, the researcher who claimed to have treated human patients with their own induced pluripotent stem cells (iPSCs), ScienceInsider reported. The dismissal came after Moriguchi admitted at a press conference in New York (October 13) that his original claim—that he had injected cardiac muscle cells derived from iPSCs into the hearts of five patients and seen positive therapeutic effects—was false.

But Moriguchi maintains that the procedure was carried out on a single patient—not at Harvard General Hospital in February 2012, as he originally claimed, but last June at a Boston hospital he declined to name.

Moriguchi’s claims, presented at the New York Stem Cell Foundation meeting at Rockefeller University, New York, quickly raised suspicions. Alerted to the story by Nature, spokespersons for the Massachusetts General Hospital (MGH) and Harvard Medical School—listed as collaborating institutions on his papers—denied that the procedures had taken place there. Moriguchi was a visiting fellow at Harvard for just one month in late 2009, they said. Moreover, several scientists named as collaborators have distanced themselves from any of the clinical work claimed by Moriguchi.

Although he admitted making some “procedural” mistakes, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Dan Cossins

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours